Gainers

IMV, Inc. IMV shares surged 99.01% to $4.04 during Wednesday's pre-market session. The most recent rating by B. Riley FBR, on Feb 28, is at Buy, with a price target of $7.

Vaxart, Inc. VXRT shares increased by 49.22% to $2.88.

Achieve Life Sciences, Inc. ACHV shares moved upwards by 44.18% to $0.39. The most recent rating by H.C. Wainwright, on Feb 25, is at Buy, with a price target of $2.

BioNTech, Inc. BNTX shares moved upwards by 42.64% to $95. The most recent rating by JP Morgan, on Mar 18, is at Neutral, with a price target of $33.

Neon Therapeutics, Inc. NTGN shares rose 20.99% to $3.17. The most recent rating by Morgan Stanley, on Jan 21, is at Equal-Weight, with a price target of $2.

DBV Technologies, Inc. DBVT shares rose 20.60% to $2.81. The most recent rating by Stifel, on Mar 17, is at Hold, with a price target of $6.

T2 Biosystems, Inc. TTOO stock moved upwards by 15.71% to $0.37.

Heat Biologics, Inc. HTBX stock increased by 14.07% to $0.69. The most recent rating by Maxim Group, on Feb 6, is at Buy, with a price target of $1.

Diffusion Pharmaceuticals, Inc. DFFN stock rose 12.28% to $0.32.

OpGen, Inc. OPGN stock moved upwards by 3.76% to $3.31.

 

Losers

Cronos Group, Inc. CRON stock fell 13.59% to $5.15 during Wednesday's pre-market session.

Moleculin Biotech, Inc. MBRX stock plummeted 10.98% to $0.46.

Sanofi, Inc. SNY stock fell 8.92% to $39.72. According to the most recent rating by Goldman Sachs, on Mar 11, the current rating is at Buy.

Canopy Growth, Inc. CGC shares decreased by 8.48% to $9.50. The most recent rating by Stifel Nicolaus, on Feb 18, is at Buy, with a price target of $35.

Royal Philips, Inc. PHG shares declined 8.32% to $31.18. The most recent rating by Bank of America, on Jan 13, is at Buy, with a price target of $51.

Grifols, Inc. GRFS shares plummeted 7.53% to $16.33.

Alcon, Inc. ALC shares plummeted 7.37% to $43.93. According to the most recent rating by UBS, on Mar 13, the current rating is at Buy.

Rite Aid, Inc. RAD stock decreased by 7.32% to $15.70.

Galapagos, Inc. GLPG shares declined 6.37% to $147.65. The most recent rating by RBC Capital, on Mar 18, is at Sector Perform, with a price target of $157.

GNC Holdings, Inc. GNC shares decreased by 6.23% to $0.45. The most recent rating by Jefferies, on Mar 17, is at Underperform, with a price target of $0.

Market News and Data brought to you by Benzinga APIs

Posted In: